Skip to main content
. 2022 Aug 8;167(10):1931–1946. doi: 10.1007/s00705-022-05545-0

Fig. 3.

Fig. 3

Inhibitory effect of camostat and nafamostat on SARS-CoV-2 entry into the cell. Because TMPRSS2 plays a key role in virus entry, the serine protease inhibitors camostat and nafamostat can inhibit virus cell entry by blocking TMPRSS2.